Astellas Pharma is focusing on diversification, with its portfolio spanning cancer, vision loss and menopause treatments. Its Chief Medical Officer, Tadaaki Taniguci, said the company was also expanding its gene therapy output, using acquisitions and licensing to build capability, while in oncology, the firm’s lead drugs include treatments for prostate and bladder cancer. Astellas is also testing a small molecule for treating menopause symptoms.
New Malware Loaders Use Call Stack Spoofing, GitHub C2, and .NET Reactor for Stealth
An updated version of a malware loader, known as Hijack Loader, has been discovered with new features aimed at evading detection and maintaining persistence. The
